Scienture Holdings (SCNX) Current Assets (2013 - 2026)
Scienture Holdings' (SCNX) quarterly Current Assets came in at $9.2 million in Q2 2026, up 974.2% year-over-year from $856625.0 in Q2 2025, and up 92.75% quarter-over-quarter from $4.8 million in Q1 2026.
Analysis
Scienture Holdings (SCNX) Current Assets (2013 - 2026) Analysis & Trends
Scienture Holdings has disclosed Current Assets across 14 years of filings, most recently posting $9.2 million for Q2 2026.
- In Q2 2026, Current Assets rose 974.2% year-over-year to $9.2 million; the TTM figure through Jun 2026 stood at $9.2 million (up 974.2% YoY), while the FY2025 annual figure was $7.9 million, up 25.55% from the prior year.
- Current Assets came in at $9.2 million for Q2 2026 at Scienture Holdings, up from $4.8 million in the prior quarter.
- In the past five years, Current Assets ranged from a high of $14.0 million in Q1 2024 to a low of $856625.0 in Q2 2025.
- Average Current Assets over 5 years is $5.7 million, with a median of $4.8 million recorded in 2026.
- Year-over-year, Current Assets sank 92.95% in 2025 and soared 974.2% in 2026.
- Over 5 years, Current Assets stood at $2.1 million in 2022, then surged by 31.53% to $2.8 million in 2023, then surged by 129.03% to $6.3 million in 2024, then rose by 25.55% to $7.9 million in 2025, then increased by 16.24% to $9.2 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $9.2 million in Q2 2026, $4.8 million in Q1 2026, and $7.9 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 13.76 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 10.06 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 3.16 Bn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 1.95 Bn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 6.52 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 825.43 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 544.97 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 630.95 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 72.50 Mn |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 | 9.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.20 Mn |
| Mar 31, 2026 | 4.77 Mn |
| Dec 31, 2025 | 7.92 Mn |
| Jun 30, 2025 | 856,625.00 |
| Mar 31, 2025 | 7.83 Mn |
| Dec 31, 2024 | 6.31 Mn |
| Jun 30, 2024 | 12.14 Mn |
| Mar 31, 2024 | 14.03 Mn |
| Dec 31, 2023 | 2.75 Mn |
| Sep 30, 2023 | 5.55 Mn |
| Jun 30, 2023 | 2.10 Mn |
| Dec 31, 2022 | 2.09 Mn |
| Sep 30, 2022 | 2.37 Mn |
| Jun 30, 2022 | 3.35 Mn |
| Mar 31, 2022 | 3.60 Mn |
| Dec 31, 2021 | 4.37 Mn |
| Sep 30, 2021 | 5.19 Mn |
| Jun 30, 2021 | 6.54 Mn |
| Mar 31, 2021 | 9.16 Mn |
| Dec 31, 2020 | 9.22 Mn |